Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

591 public trials 87 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

NCT00135694

Conditions
Behavior, Blood-Borne Infections, Chronic Disease, +18 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado Denver, Colorado, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Completed

Hepatitis B Vaccine for Non-responders

NCT03415672

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Vaxinfectio - Antwerp University Antwerp, Belgium
  • Ziekenhuis Oost-Limburg Genk, Belgium
  • Maastricht UMC Maastricht, Netherlands
View Trial Details
Completed

Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation

NCT01421212

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Jackson Memorial Hospital / University of Miami Miami, Florida, United States
View Trial Details
Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

NCT02350569

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • San Francisco, California, United States
  • Chicago, Illinois, United States
  • New Orleans, Louisiana, United States
  • Detroit, Michigan, United States
View Trial Details
Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

NCT01768286

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +17 more
Locations
  • Phoenix, Arizona, United States
  • Tucson, Arizona, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 53 locations
View Trial Details

Related conditions